跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ARIDOL - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ARIDOL
Authorized
STANDARD
ARIDOL
PHARMAXIS EUROPE LIMITED
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
126e92960791c5de
Company
PHARMAXIS EUROPE LIMITED
Type
Standard
Approval Details
Approval Id
126e92960791c5de
Drug Approval Canada Name
ARIDOL
Product Name
ARIDOL
Status
Marketed
Status Date
2024-07-30
Original Market Date
2020-06-15
Din
02489562
Drug Class
Human
Dosage Form
Powder , Kit
Route Of Administration
Inhalation
Schedule
Prescription Recommended
Ahfs
36:00.00
Atc Original
V04CX OTHER DIAGNOSTIC AGENTS
Atc Name
v 04 cx
Aig Number
0461510001
Company Name
PHARMAXIS EUROPE LIMITED
Company Address
108 Q House, Furze Road, Sandyford, Dublin, Ireland, D18AY29
Company Detail Path
/organization/pharmaxis-europe-limited
Company Information
Pharmaceutical Company Name
PHARMAXIS EUROPE LIMITED
Country Name
Ireland
City Name
dublin,country_ie
Address
Sandyford Business Park, Suite 108, Q house
Active Ingredients
MANNITOL
10 MG / CAP
MANNITOL
40 MG / CAP
MANNITOL
20 MG / CAP
MANNITOL
5 MG / CAP
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
126e92960791c5de
Type
Standard
Back to Health Canada Approvals